Join Dow CEO Jim Fitterling, an expert in market outlook and sustainability, and Mark Eramo, co-president of S&P Global, as they uncover the current state of the chemical industry. They discuss the impact of geopolitical tensions on market dynamics and the importance of the energy transition. The duo emphasizes the necessity of adopting a circular economy to address plastic waste while navigating the challenges of decarbonization. They also explore how AI and digital technologies can revolutionize operational efficiencies in the sector.

Jim Fitterling, Chair and CEO of Dow Inc., discusses his pivotal role in the transformative merger with DuPont, creating three distinct businesses. He emphasizes the vital importance of innovation and customer-centricity in today’s competitive market. Fitterling touches on the challenges of fostering inclusivity and maintaining morale post-merger. He also shares insights on sustainability efforts and the need for transparency to bolster client loyalty, driving a supportive organizational culture that enhances employee engagement.

Dow CEO Jim Fitterling discusses volume growth in the chemicals industry, including insights on macro economic backdrop, sector growth, global chemical prices, and market trends. The discussion covers automotive, electronics, pharma, packaging, housing sectors, demand growth, industrial market trends, China's chemical franchises, Europe's advantages in energy costs, and the impact of lower feedstock and energy costs on earnings and global cost advantages.

Topics include Unilever's split, Boeing's cash drain prediction, Intel's government grant, potential TikTok ban in US, and Dow Chemical CEO discussing high power prices in Europe

Topics include Dow Chemical's CEO perspectives on the economy, analysis of Federal Reserve's decisions, market expectations, and Oprah's unofficial advocacy for weight-loss drugs. Insights on energy market predictions, small business financial management, and the impact of pharmaceutical companies meeting the demand for weight loss medications.